Christoph Huber

Directeur Général chez tonestro

Profil

Christoph Huber was the founder of Ganymed Pharmaceuticals AG, serving as Vice Chairman-Supervisory Board since 2001.
Dr. Huber was the founder of BioNTech SE, serving as Member-Supervisory Board from 2008 to 2023.
Dr. Huber is also the founder of tonestro.
Dr. Huber currently holds the position of Chairman at Association For Cancer Immunotherapy.
Dr. Huber currently holds the position of Deputy Chairman-Supervisory Board at Tirol Kliniken GmbH.
Dr. Huber currently holds the position of Director at Ci3 Management UG.
Dr. Huber currently holds the position of Member-Supervisory Board at AFFiRiS AG since 2015.
Dr. Huber currently holds the position of Advisory Board at Onsight Ventures Management GmbH.
Former positions include Chairman-Hematology & Oncology Department at The Johannes Gutenberg University of Mainz.
Former positions include Member-Supervisory Board at TRON - Translationale Onkologie an der Universitätsmedizin der from 2018 to 2019.
Education includes a doctorate from the University of Innsbruck.

Postes actifs de Christoph Huber

Sociétés	Poste	Début
Association For Cancer Immunotherapy	Président	-
Ci3 Management UG	Directeur/Membre du Conseil	-
AFFiRiS AG	Directeur/Membre du Conseil	18/05/2015
TILAK-Tiroler Landeskrankenanstalten GmbH	Directeur/Membre du Conseil	-
tonestro	Directeur Général	-
Onsight Ventures	Consultant / Advisor	-

Anciens postes connus de Christoph Huber

Sociétés	Poste	Fin
BIONTECH SE	Fondateur	25/05/2023
TRON - Translationale Onkologie an der Universitätsmedizin der	Directeur/Membre du Conseil	01/04/2019
The Johannes Gutenberg University of Mainz	Corporate Officer/Principal	-
░░░░░░░ ░░░░░░░░░░░░░░░ ░░	░░░░░░░░░	-